Anti-amyloid therapies work for Alzheimer's disease

被引：0
|
作者：
Hardy, John [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] UCL Inst Neurol, Reta Lilla Weston Res Labs, London WC1N 3BG, England
[2] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England
[3] UCL Inst Neurol, Dementia Res Inst, London WC1N 3BG, England
[4] UCL Inst Neurol, Reta Lilla Weston Res Labs, Queen Sq, London WC1N 3BG, England
[5] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England
[6] UCL Inst Neurol, Dementia Res Inst, Queen Sq, London WC1N 3BG, England
来源：
BRAIN COMMUNICATIONS | 2023年 / 5卷 / 04期
关键词：
TAU;
D O I：
10.1093/braincomms/fcad204
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Transgenic amyloid precursor protein mousemodels of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti-amyloid therapies
    Morgan, David G.
    Lamb, Bruce T.
    ALZHEIMERS & DEMENTIA, 2024, 20 (02) : 1459 - 1464
  • [42] Alzheimer's disease: Progress in the development of anti-amyloid disease-modifying therapies (vol 13, pg 113, 2007)
    Christensen, D. D.
    CNS SPECTRUMS, 2007, 12 (03) : 183 - 183
  • [43] Development of a Platinum Complex as an anti-Amyloid Agent for the Therapy of Alzheimer's Disease
    Kenche, Vijaya B.
    Hung, Lin W.
    Perez, Keyla
    Volitakes, Irene
    Ciccotosto, Guiseppe
    Kwok, Jeffrey
    Critch, Nicole
    Sherratt, Nikki
    Cortes, Mikhalina
    Lal, Varsha
    Masters, Colin L.
    Murakami, Kazuma
    Cappai, Roberto
    Adlard, Paul A.
    Barnham, Kevin J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (12) : 3374 - 3378
  • [44] Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease
    Castello, Michael A.
    Jeppson, John David
    Soriano, Salvador
    BMC NEUROLOGY, 2014, 14
  • [45] Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer's disease
    Gandy, S
    NEUROBIOLOGY OF AGING, 2002, 23 (06) : 1009 - 1016
  • [46] Anti-amyloid precursor protein antibodies as a potential therapy for Alzheimer's disease
    Kidd, Emma J.
    Hvoslef-Eide, Martha
    Thomas, Rhian S.
    NEUROREPORT, 2014, 25 (03) : 145 - 145
  • [47] Patient journey and decision processes for anti-amyloid therapy in Alzheimer’s disease
    Brant Mittler
    Xavier Cambi
    Morgan Biskach
    Joel Reisman
    Ying Wang
    Dan Berlowitz
    Peter Morin
    Donald R. Miller
    Karla Brandao-Viruet
    Sophie J. Clare
    Kevin Z. Xia
    Amir Abbas Tahami Monfared
    Michael Irizarry
    Quanwu Zhang
    Weiming Xia
    Journal of Neurology, 2025, 272 (5)
  • [48] A Multilevel Study of Eupatorin and Scutellarein as Anti-Amyloid Agents in Alzheimer′s Disease
    Rizou, Aikaterini E. I.
    Nasi, Georgia I.
    Paikopoulos, Yiorgos
    Bezantakou, Dimitra S.
    Vraila, Konstantina D.
    Spatharas, Panagiotis M.
    Dimaki, Virginia D.
    Papandreou, Nikos C.
    Lamari, Fotini N.
    Chondrogianni, Niki
    Iconomidou, Vassiliki A.
    BIOMEDICINES, 2023, 11 (05)
  • [49] Monoclonal anti-amyloid antibodies for the treatment of Alzheimer's disease and the hesitant geriatrician
    Chin, Nathaniel A.
    Widera, Eric
    Brangman, Sharon A.
    Karlawish, Jason
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (02) : 643 - 645
  • [50] Anti-amyloid therapies: are they effective and safe?
    Perneczky, R.
    EUROPEAN PSYCHIATRY, 2024, 67 : S17 - S17
12345